These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20100034)

  • 41. Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: the influence of flow and volume.
    Yakubu SI; Assi KH; Chrystyn H
    Int J Pharm; 2013 Oct; 455(1-2):213-8. PubMed ID: 23892154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.
    Johnson JC; Waldrep JC; Guo J; Dhand R
    Respir Care; 2008 Dec; 53(12):1703-8. PubMed ID: 19025706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.
    Abdelrahim ME
    Respir Med; 2010 May; 104(5):682-9. PubMed ID: 20004090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: Design.
    Marple VA; Roberts DL; Romay FJ; Miller NC; Truman KG; Van Oort M; Olsson B; Holroyd MJ; Mitchell JP; Hochrainer D
    J Aerosol Med; 2003; 16(3):283-99. PubMed ID: 14572326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reducing bounce effects in the Andersen cascade impactor.
    Dunbar C; Kataya A; Tiangbe T
    Int J Pharm; 2005 Sep; 301(1-2):25-32. PubMed ID: 16023806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of cascade impaction and laser diffraction for particle size distribution measurements.
    Ziegler J; Wachtel H
    J Aerosol Med; 2005; 18(3):311-24. PubMed ID: 16181006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new approach to characterise pharmaceutical aerosols: measurement of aerosol from a single dose aqueous inhaler with an optical particle counter.
    Kuhli M; Weiss M; Steckel H
    Eur J Pharm Sci; 2010 Jan; 39(1-3):45-52. PubMed ID: 19874891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reconciliation of Cascade Impaction during Wet Nebulization.
    Solomita M; Smaldone GC
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):11-8. PubMed ID: 19392585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous nebulization therapy for asthma with aerosols of beta2 agonists.
    Raabe OG; Wong TM; Wong GB; Roxburgh JW; Piper SD; Lee JI
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):499-508. PubMed ID: 9647274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Particle-size distribution of bitolterol mesylate solution delivered by four compressed-air nebulizer devices.
    Hunke WA; Yu AB
    Am J Hosp Pharm; 1987 Jun; 44(6):1392-6. PubMed ID: 3618619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of High-Power Electronic Nicotine Delivery System as an Alternative Aerosol Device for Terbutaline Delivery.
    Chaoui M; Chevrel S; Perinel-Ragey S; Prévôt N; Pourchez J
    Pharm Res; 2022 Mar; 39(3):587-597. PubMed ID: 35137358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of aerosol output from various nebulizer/compressor combinations.
    Reisner C; Katial RK; Bartelson BB; Buchmeir A; Rosenwasser LJ; Nelson HS
    Ann Allergy Asthma Immunol; 2001 May; 86(5):566-74. PubMed ID: 11379809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of nonideal cascade impactor stage collection efficiency curves on the interpretation of the size of inhaler-generated aerosols.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2013 Jun; 14(2):497-510. PubMed ID: 23508617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Numerical calibration of the Andersen cascade impactor using a single jet model.
    Gulak Y; Jayjock E; Muzzio F; Bauer A; McGlynn P
    Int J Pharm; 2009 Jul; 377(1-2):45-51. PubMed ID: 19464352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhalation and deposition of nebulized sodium cromoglycate in two different particle size distributions in children with asthma.
    Nerbrink OL; Lindström M; Meurling L; Svartengren M
    Pediatr Pulmonol; 2002 Nov; 34(5):351-60. PubMed ID: 12357479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New ipratropium formulation to decrease nebulization time.
    Majoral C; Vecellio L; Grimbert D; de Monte M; le Guellec C; Ingremeau V; Minois C; Cordeau E; Paintaud G; Steinberg A; Diot P
    Respir Med; 2007 Feb; 101(2):237-45. PubMed ID: 16854578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation of a Sustained-Release Nebulized Aerosol of R-terbutaline Hydrochloride Liposome and Evaluation of Its Anti-asthmatic Effects via Pulmonary Delivery in Guinea Pigs.
    Li Q; Zhan S; Liu Q; Su H; Dai X; Wang H; Beng H; Tan W
    AAPS PharmSciTech; 2018 Jan; 19(1):232-241. PubMed ID: 28681333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.